HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hydrops fetalis associated with homozygosity for hemoglobin Taybe (alpha 38/39 THR deletion) in newborn triplets.

Abstract
Hemoglobin Taybe is an unstable alpha-chain hemoglobin variant caused by a deletion of a threonine residue at codon 38 or 39 of the alpha-1 globin chain. We describe preterm infant triplets born with hydrops fetalis and anemia who were found by DNA analysis to be homozygous for hemoglobin Taybe. All three infants developed intrauterine hemolytic anemia, which subsequently led to hydrops fetalis. To the best of our knowledge, this is the first description of hydrops fetalis associated with this hemoglobinopathy. We suggest that hemoglobin Taybe be considered in the differential diagnosis of hydrops fetalis and that known affected fetuses be carefully followed both antenatally and postnatally.
AuthorsShmuel Arnon, Hannah Tamary, Orly Dgany, Ita Litmanovitz, Rivka Regev, Sofia Bauer, Tzipora Dolfin, Joanne Yacobovich, Baruch Wolach, Lutfi Jaber
JournalAmerican journal of hematology (Am J Hematol) Vol. 76 Issue 3 Pg. 263-6 (Jul 2004) ISSN: 0361-8609 [Print] United States
PMID15224363 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright 2004 Wiley-Liss, Inc.
Chemical References
  • Hemoglobins, Abnormal
  • hemoglobin Taybe
  • Globins
  • DNA
Topics
  • Adult
  • Anemia, Hemolytic (genetics)
  • Consanguinity
  • DNA (blood)
  • Erythrocyte Transfusion
  • Female
  • Fetal Diseases (genetics)
  • Gene Deletion
  • Globins (genetics)
  • Hemoglobins, Abnormal (genetics)
  • Homozygote
  • Humans
  • Hydrops Fetalis (blood, genetics)
  • Infant, Newborn
  • Infant, Premature
  • Intensive Care, Neonatal
  • Male
  • Polymerase Chain Reaction
  • Pregnancy
  • Triplets

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: